Pharma

ProKidney is going public in a SPAC merger that infuses the biotech with $825 million for Phase 3 tests and manufacturing...

The deal between Stamford, Connecticut-based Sema4 and GeneDx’s parent, Miami-based OPKO Health, was fortified with a $200...

Managing the healthcare workforce can be a challenge for providers, particularly in the current environment. There has...

Asia-Pacific was the fastest growing region for data analytics hiring among pharmaceutical industry companies in the three...

The FDA rejected the new drug application for a Levo Therapeutics treatment for the rare metabolic disorder Prader-Willi...

This content is password protected. To view it please enter your password below: Password: The post Protected: Eight pharma...

A growing number of transition programs are focused on healthcare planning – helping formerly incarcerated individuals with...

Abbisko Therapeutics and Eli Lilly and Company have signed a global partnership and exclusive licencing agreement to...

Yuvo Health announced Tuesday that it has raised $7.3 million to support the company’s work with federally qualified health...

The wait is over: AbbVie’s Rinvoq chalks up FDA win with favorable atopic dermatitis label aliu Tue, 01/18/2022 - 10:44

Inside the Catalent FDA citation said to trigger Novo Nordisk's Wegovy supply hiccup fkansteiner Tue, 01/18/2022 - 09:39

Moderna is aiming to market a Covid-19 and influenza booster vaccine combo within the next two years, CEO Stéphane Bancel...

The US Food and Drug Administration (FDA) has granted priority review for AstraZeneca and Daiichi Sankyo’s Enhertu...

The NHS launches world-first study investigating genetic testing for common diseases

Cancer Research UK announces clinical trial for most common type of lung cancer